Company Beijing Succeeder Technology Inc.

Equities

688338

CNE1000044C4

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Beijing Succeeder Technology Inc.

EPS Revisions

Annual profits - Rate of surprise

Sector Diagnostic & Testing Substances

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-06 EDT			5-day change	1st Jan Change
25.42 ^CNY	+0.99%		+1.76%	-24.35%

04-24	Beijing Succeeder Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01-15	Beijing Succeeder Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Beijing Succeeder Technology Inc is a China-based company mainly engaged in the research and development, production and sales of testing instruments, reagents and consumables in the field of thrombosis and hemostasis in vitro diagnosis. The Company provides medical institutions with automated detection equipment for blood coagulation, blood rheology, hematocrit, platelet aggregation, and supporting reagents and consumables. Its products include testing instruments, reagents and consumables, such as automatic coagulation testers, coagulation quality control kits, Newtonian fluid quality controls, reaction cups and SAW blood rheology special cleaning. The Company operates its businesses within the domestic market and to overseas markets.

Number of employees: 273

CNY in Million	2022	Weight	2023	Weight	Delta
Reagents - Coagulation 57.5 %	132	57.6 %	158	57.5 %	+20.16%
Consumables - Coagulation 19.4 %	48	20.9 %	53	19.4 %	+12.00%
Instrument - Coagulation 15.5 %	32	13.9 %	43	15.5 %	+34.35%
Instrument - Blood Flow Variable 3.5 %	9	3.8 %	10	3.5 %	+10.13%
Consumables - Blood Flow Variable Consumption Material 1.8 %	4	1.8 %	5	1.8 %	+26.21%
Instrument - Other 1.6 %	3	1.3 %	4	1.6 %	+51.78%
Reagents - Blood Flow Change Test Agent 0.5 %	1	0.5 %	1	0.5 %	+8.28%
Other Business 0.2 %	1	0.3 %	0	0.2 %	-15.78%
Consumables - Other 0.0 %	0	0.0 %	0	0.0 %	+92.86%

CNY in Million	2022	Weight	2023	Weight	Delta
China 96.0 %	224	98.0 %	264	96.0 %	+18.07%
Overseas 4.0 %	5	2.0 %	11	4.0 %	+138.26%

Managers	Title	Age	Since
Shi Ming Wu FOU	Founder	67	03-05-27
Hai Wang CEO	Chief Executive Officer	53	19-08-31
Guo Li DFI	Director of Finance/CFO	47	16-05-29
Ying Zhang CHM	Chairman	52	02-12-31
Xiao Juan Hu CTO	Chief Tech/Sci/R&D Officer	40	15-05-31
Jun Yan BRD	Director/Board Member	36	15-06-30
Chen Pan BRD	Director/Board Member	36	08-04-30
Guo Bin Liu BRD	Director/Board Member	38	11-03-31
Tong Wu BRD	Director/Board Member	40	07-07-31
Xu Wang BRD	Director/Board Member	46	08-12-31

Members of the board	Title	Age	Since
Shi Ming Wu FOU	Founder	67	03-05-27
Chong Hui Ding BRD	Director/Board Member	51	04-06-30
Xiao Feng Gu BRD	Director/Board Member	53	04-03-31
Xu Wang BRD	Director/Board Member	46	08-12-31
Guo Li DFI	Director of Finance/CFO	47	16-05-29
Tong Wu BRD	Director/Board Member	40	07-07-31
Pei Lin Mu BRD	Director/Board Member	58	22-01-08
Guo Bin Liu BRD	Director/Board Member	38	11-03-31
Chen Pan BRD	Director/Board Member	36	08-04-30
Jun Yan BRD	Director/Board Member	36	15-06-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	106,142,400	40,276,383 ( 37.95 %)	0	37.95 %

Name	Equities	%	Valuation
Penghua Fund Management Co., Ltd. 4.900 %	3,120,464	4.900 %	11 M ¥
GF Fund Management Co., Ltd. 4.352 %	2,771,695	4.352 %	10 M ¥
HuaAn Fund Management Co., Ltd. 2.143 %	1,365,040	2.143 %	5 M ¥
China Southern Asset Management Co., Ltd. 1.959 %	1,247,513	1.959 %	4 M ¥
Fullgoal Fund Management Co., Ltd. 1.325 %	843,989	1.325 %	3 M ¥
ICBC Credit Suisse Asset Management Co., Ltd. 0.6607 %	420,800	0.6607 %	1 M ¥
Bank of Communications Schroder Fund Management Co., Ltd. 0.4787 %	304,884	0.4787 %	1 M ¥
Huatai-PineBridge Fund Management Co., Ltd. 0.3556 %	226,494	0.3556 %	784 392 ¥
China Asset Management Co., Ltd. 0.3499 %	222,858	0.3499 %	771 800 ¥
Zheshang Fund Management Co., Ltd. 0.3085 %	196,470	0.3085 %	680 413 ¥

Beijing Succeeder Technology, Inc.

8/F, Building 1 7, Science Park Road

102200, Beijing

http://www.succeeder.com.cn

address Beijing Succeeder Technology Inc.(688338)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

25.42

Average target price

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
BEIJING SUCCEEDER TECHNOLOGY INC.	-24.35%	374M
BIOMÉRIEUX	-0.20%	12.71B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-1.68%	8.37B
DIASORIN S.P.A.	-0.06%	5.4B
LANTHEUS HOLDINGS, INC.	+22.60%	5.27B
AUTOBIO DIAGNOSTICS CO., LTD.	+1.03%	4.63B
10X GENOMICS, INC.	-53.29%	3.13B
ANDON HEALTH CO., LTD.	+13.22%	2.77B
VITROLIFE AB	-8.47%	2.25B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-0.46%	1.95B

Diagnostic & Testing Substances